Literature DB >> 18556814

Expression of recombinant human epidermal growth factor in Escherichia coli and characterization of its biological activity.

Ahmad Faizal Abdull Razis1, Elysha Nur Ismail, Zarida Hambali, Muhammad Nazrul Hakim Abdullah, Abdul Manaf Ali, Mohd Azmi Mohd Lila.   

Abstract

Recombinant human epidermal growth factor (EGF) was successfully expressed as a fusion protein in Escherichia coli system. This system was used OmpA signal sequence to produce soluble protein into the periplasm of E. coli. Human EGF (hEGF) synthesized in bacterial cell was found to be similar in size with the original protein and molecular weight approximately at 6.8 kDa. Cell proliferation assay was conducted to characterize the biological activity of hEGF on human dermal fibroblasts. The synthesized hEGF was found to be functional as compared with authentic hEGF in stimulating cell proliferation and promoting growth of cell. In comparison of biological activity between synthesized and commercial hEGF on cell proliferation, the results showed there was no significant different. This finding indicates the synthesized hEGF in E. coli system is fully bioactive in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556814     DOI: 10.1007/s12010-007-8019-9

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  12 in total

1.  Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.

Authors:  Jonathan K Pokorski; Marisa L Hovlid; M G Finn
Journal:  Chembiochem       Date:  2011-09-29       Impact factor: 3.164

2.  High-level expression and purification of heparin-binding epidermal growth factor (HB-EGF) with SUMO fusion.

Authors:  Wuguang Lu; Peng Cao; Huangzong Lei; Shuangquan Zhang
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

3.  Activity and Effectiveness of Recombinant hEGF Excreted by Escherichia coli BL21 on Wound Healing in Induced Diabetic Mice.

Authors:  Sriwidodo Sriwidodo; Iman Permana Maksum; Toto Subroto; Nasrul Wathoni; Anas Subarnas; Abd Kakhar Umar
Journal:  J Exp Pharmacol       Date:  2020-09-29

4.  Functional EGF domain of the human neuregulin 1α produced in Escherichia coli with accurate disulfide bonds.

Authors:  Arthur Schveitzer Ferreira; Amanda Lopacinski; Michel Batista; Priscila Mazzocchi Hiraiwa; Natalia Fernanda Bueno; Beatriz Gomes Guimarães; Nilson I T Zanchin
Journal:  Mol Biol Rep       Date:  2022-10-05       Impact factor: 2.742

5.  Economic optimization of expression of soluble human epidermal growth factor in Escherichia coli.

Authors:  Kun Liu; Feng-Qing Wang; Ming Zhao; Bei Gao; Hong Xu; Dongzhi Wei
Journal:  Biotechnol Lett       Date:  2022-10-21       Impact factor: 2.716

6.  Efficient production of human zona pellucida-3 in a prokaryotic expression system.

Authors:  Zhuolin Qiu; Mingzhu Wang; Miaoqin She; Qianmei Chen; Qingqing Li; Jianbin Zhu; Xiaorong Yang; Xiangsheng Cai
Journal:  World J Microbiol Biotechnol       Date:  2018-10-19       Impact factor: 3.312

7.  Periplasmic Expression of TNF Related Apoptosis Inducing Ligand (TRAIL) in E.coli.

Authors:  Omid Tavallaei; Mojgan Bandehpour; Nastaran Nafissi-Varcheh; Bahram Kazemi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

8.  Cloning, Expression, and Cost Effective Purification of Authentic Human Epidermal Growth Factor With High Activity.

Authors:  Sara Pouranvari; Firouz Ebrahimi; Gholamreza Javadi; Bozorgmehr Maddah
Journal:  Iran Red Crescent Med J       Date:  2016-03-20       Impact factor: 0.611

9.  Piperonylic acid stimulates keratinocyte growth and survival by activating epidermal growth factor receptor (EGFR).

Authors:  Dohyun Lee; Jinsun Lim; Kyung-Chul Woo; Kyong-Tai Kim
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

10.  Cloning, expression and functional characterization of in-house prepared human basic fibroblast growth factor.

Authors:  Hassan Rassouli; Mohammad Sharif Tabe Bordbar; Mehran Rezaei Larijani; Mohammad Pakzad; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.